乳糖酶治疗小儿腹泻病的临床分析  

Clinical analysis of infantile diarrhea treatment with lactase

作　　者：顾岚[1] 王叶红[1] 胥玲[1] 

机构地区：[1]南京医科大学附属无锡人民医院,江苏无锡214023

出　　处：《中国微生态学杂志》2013年第7期819-820,823,共3页Chinese Journal of Microecology

摘　　要：目的研究小儿腹泻病继发乳糖不耐受的年龄、病因及乳糖酶治疗继发乳糖不耐受的效果。方法对382例腹泻继发乳糖不耐受患儿进行年龄、病因分析,同时将患儿分成治疗及对照两组,分析乳糖酶的疗效。结果小儿腹泻继发乳糖不耐受以婴幼儿多见,轮状病毒感染是继发乳糖不耐受的主要病因,乳糖酶治疗继发乳糖不耐受疗效显著。结论婴幼儿腹泻常规给予乳糖酶可以缩短病程,减少治疗费用,患儿及家长易于接受。Objective To investigate the age and causes of infantile secondary lactose intolerance causing diarrhea and the efficacy of lactase in treatment of the disease.Methods 382 cases of diarrhea secondary to lactose intolerance were analyzed in regard to the causes and age.Patients were divided into treatment and control groups for analysis of the efficacy of lactase.Results Infantile diarrhea secondary to lactose intolerance were more common in infants and young children;rotavirus infection was a major cause of secondary lactose intolerance;lactase had significant effect for treatment of secondary lactose intolerance.Conclusion Routine administration of lactase can be used to treat diarrhea in infants and young children to shorten the course and reduce the cost of treatment,which is an acceptable way for both the patients and their parents.

关 键 词：乳糖不耐受 乳糖酶 轮状病毒 小儿 

分 类 号：R725.7[医药卫生—儿科]